Anthropic is making biotech boasts, but scientists are wary of hype around ‘curing cancer’
AI-generated summary Anthropic has been promoting its biotechnology initiatives by opening a Bay Area biology lab, purchasing two biotech startups, and partnering with drugmakers such as Novo and Bristol Myers Squibb. While CEO Dario Amodei has made bold predictions about biological progress and curing cancer, medical professionals and industry experts warn that most drugs fail in clinical trials.